Leaflet GLYCOPHOS 216mg / ml concentrate for solution for infusion


Indicated for: mineral deficiency; mineral supplementation

Route of administration: infusion

Substance: glycerophosphate (mineral)

ATC: B05XA14 (Blood and blood forming organs | I.v. solution additives | Electrolyte solutions)

Glycerophosphate is a compound used in dietary supplements and medical treatments to support energy metabolism and bone health. It is a source of phosphorus and glycerol, essential for cellular function.

This compound is often used to treat phosphorus deficiencies or to support recovery in cases of chronic fatigue, stress, or intense physical effort. It may also be used in combination with other minerals.

Glycerophosphate is generally well-tolerated but may cause side effects such as nausea or stomach discomfort. In rare cases, allergic reactions may occur.

It is important to use glycerophosphate as directed by your doctor or pharmacist and to report any side effects or unusual symptoms.

General data about GLYCOPHOS 216mg / ml

  • Substance: glycerophosphate
  • Date of last drug list: 01-05-2026
  • Commercial code: W42748003
  • Concentration: 216mg / ml
  • Pharmaceutical form: concentrate for solution for infusion
  • Packing volume: 20ml
  • Product type: original
  • Price: 204.79 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: FRESENIUS KABI NORGE AS - NORVEGIA
  • Holder: FRESENIUS KABI AB - SUEDIA
  • Number: 7324/2015/02
  • Shelf life: 3 years